J3570 HCPCS Level II code: Laetrile, amygdalin, vitamin b17
J3570 is the HCPCS code for “Laetrile, amygdalin, vitamin b17” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J3570Laetrile, amygdalin, vitamin b17
Short description: Laetrile amygdalin vit b17
HCPCS · United States
Medicare details
The indicators CMS publishes with J3570 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Non-covered by Medicare
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1986
Where J3570 sits
- 1J codesDrugs administered other than orally
- 2Active code J3570Laetrile, amygdalin, vitamin b17
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J3570 mean?
J3570 is the HCPCS code for “Laetrile, amygdalin, vitamin b17” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J3570?
CMS lists J3570’s Medicare coverage as “Non-covered by Medicare” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J3570
All J codesJ3486Injection, ziprasidone mesylate, 10 mgJ3489Injection, zoledronic acid, 1 mgJ3490Unclassified drugsJ3520Edetate disodium, per 150 mgJ3530Nasal vaccine inhalationJ3535Drug administered through a metered dose inhalerJ3590Unclassified biologicsJ3591Unclassified drug or biological used for esrd on dialysisJ7030Infusion, normal saline solution , 1000 ccJ7040Infusion, normal saline solution, sterile (500 ml = 1 unit)J70425% dextrose/normal saline (500 ml = 1 unit)J7050Infusion, normal saline solution, 250 cc